Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-A1904 in Advanced Colorectal Cancer
NCT07700719Phase 2Not yet recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jul 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 2 trial of garetatug rezetecan in colorectal cancer (CRC), sponsored by Peking University Cancer Hospital & Institute. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
garetatug rezetecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07700719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07700719.